Umedeor

About:

uMed enables healthcare providers to run patient research more efficiently through automating the clinical studies process

Website: http://www.umed.io

Twitter/X: u_medeor

Top Investors: Playfair Capital, PharmStars, AlbionVC, 11.2 Capital, Delin Ventures

Description:

uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access to regulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams

Total Funding Amount:

$18.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2017-11-01

Contact Email:

info(AT)umed.org

Founders:

Matt Wilson

Number of Employees:

51-100

Last Funding Date:

2023-07-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai